EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--May 15, 2006--SurModics, Inc. (Nasdaq:SRDX - News), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that it is providing advanced hydrophilic technology for the delivery system of Xtent's unique drug-eluting stent system, which is capable of delivering multiple custom-length stents to treat lesions in numerous vessels with a single procedure.
